Substituent Q Is Alkyl Patents (Class 564/98)
  • Patent number: 4276435
    Abstract: The present invention provides novel 19,20-didehydro-PG.sub.1, sulfonyl amides methods for their preparation and pharmacological use for the induction of prostaglandin-like effect.
    Type: Grant
    Filed: October 17, 1979
    Date of Patent: June 30, 1981
    Assignee: The Upjohn Company
    Inventor: John C. Sih
  • Patent number: 4276436
    Abstract: The present invention provides novel 19-keto-PG sulfonylamides, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.
    Type: Grant
    Filed: March 20, 1980
    Date of Patent: June 30, 1981
    Assignee: The Upjohn Company
    Inventor: John C. Sih
  • Patent number: 4268669
    Abstract: The present invention particularly relates to novel 9-deoxy-9-methylene-5,6-didehydro-PGF.sub.1 amides and methods for their preparation in pharmacological use.
    Type: Grant
    Filed: January 28, 1980
    Date of Patent: May 19, 1981
    Assignee: The Upjohn Company
    Inventor: Gordon L. Bundy
  • Patent number: 4267352
    Abstract: The present invention provides novel 19-hydroxy-19-methyl-6-oxo-PGF.sub.1 sulfonylamides which are useful for pharmacological purposes, e.g., anti-asthmatic indications.
    Type: Grant
    Filed: March 3, 1980
    Date of Patent: May 12, 1981
    Assignee: The Upjohn Company
    Inventor: John C. Sih
  • Patent number: 4265825
    Abstract: N-(haloalkyl)sulfonamides represented by the formula ##STR1## wherein R.sub.1 is a C.sub.1 -C.sub.20 aryl, alkaryl, aralkyl or alkyl group; R.sub.2, R.sub.3 and R.sub.4 are each independently hydrogen or methyl groups; n is the integer 0 or 1 and X is a chloro, bromo or iodo group, are prepared by reacting an N-(haloalkyl)sulfonyl imide with a C.sub.1 -C.sub.6 alkanol.
    Type: Grant
    Filed: September 17, 1979
    Date of Patent: May 5, 1981
    Assignee: The Dow Chemical Company
    Inventors: Peter W. Owen, Zita K. Harmon, Donald A. Tomalia
  • Patent number: 4264522
    Abstract: The present invention provides novel 19-hydroxy-PG amides methods for their preparation and pharmacological use for the induction of prostaglandin-like effect.
    Type: Grant
    Filed: October 26, 1979
    Date of Patent: April 28, 1981
    Assignee: The Upjohn Company
    Inventor: John C. Sih
  • Patent number: 4261925
    Abstract: Surfactants having an HLB of from about 12 to about 20, preferably 14 to about 20, are disclosed which correspond to formulas I and II: ##STR1## wherein: R.sub.1 is a nonpolymerizable hydrocarbyl or inertly-substituted hydrocarbyl group of at least 8 carbon atoms; R.sub.2 is hydrogen or alkyl; X is ##STR2## Y is a terminal inorganic or organic group; and n is at least 2.
    Type: Grant
    Filed: April 5, 1978
    Date of Patent: April 14, 1981
    Assignee: The Dow Chemical Company
    Inventors: Donald A. Tomalia, James D. Huffines
  • Patent number: 4260497
    Abstract: Novel methanesulfonamides useful as non-yellowing antistatic agents for laundered fabrics, detergent compositions containing an effective anti-static amount of said methanesulfonamide and a method of protecting fabrics against acquiring static electricity by contacting fabrics with said composition during laundering. These compounds provide antistatic protection without reducing optical brightener performance of the detergent composition.This invention relates to novel antistatic agents and detergent compositions to be used in the laundering of fabrics containing said antistatic agent which is a nitrogen substituted methansulfonamide having the formula:RNHSO.sub.2 CH.sub.3wherein R is a secondary aliphatic hydrocarbon chain of at least 8 carbons.
    Type: Grant
    Filed: November 26, 1979
    Date of Patent: April 7, 1981
    Assignee: Colgate-Palmolive Company
    Inventor: Robert A. Bauman
  • Patent number: 4257970
    Abstract: Novel N-(haloalkyl)sulfonyl imides represented by the formula ##STR1## are prepared by the reaction of a 2-alkyl- or 2-aryl-oxazoline or oxazine with an arylene or alkane sulfonyl halide. In the formula for the novel sulfonyl imide, R.sub.1 and R.sub.2 are each independently C.sub.1 -C.sub.20 aryl, alkaryl or alkyl groups; R.sub.3, R.sub.4 and R.sub.5 are each hydrogen or methyl groups; n is the integer 0 or 1 and X is a chloro, bromo or iodo group. These novel sulfonyl imides are particularly useful in the preparation of N-(2-chloroethyl)- and N-(3-chloropropyl)sulfonamides.
    Type: Grant
    Filed: September 17, 1979
    Date of Patent: March 24, 1981
    Assignee: The Dow Chemical Company
    Inventor: Donald A. Tomalia
  • Patent number: 4252978
    Abstract: The present invention provides novel 19-hydroxy-6-oxo-PGF.sub.1 sulfonylamides which are useful for pharmacological purposes, e.g., anti-asthmatic indications.
    Type: Grant
    Filed: March 3, 1980
    Date of Patent: February 24, 1981
    Assignee: The Upjohn Company
    Inventor: John C. Sih
  • Patent number: 4252813
    Abstract: Compounds of the formula ##STR1## are useful as anti-allergy agents.
    Type: Grant
    Filed: November 19, 1979
    Date of Patent: February 24, 1981
    Assignee: The Upjohn Company
    Inventor: John B. Wright
  • Patent number: 4243611
    Abstract: Prostaglandin derivatives having a 19,20-didehydro, a 19-hydroxy, or a 19-keto feature are disclosed, including processes for preparing them and the appropriate intermediates.A typical 19-hydroxy compound of this invention is 19-hydroxy-19-methyl-PGF.sub.2.alpha.
    Type: Grant
    Filed: April 2, 1979
    Date of Patent: January 6, 1981
    Assignee: The Upjohn Company
    Inventor: John C. Sih
  • Patent number: 4235930
    Abstract: Prostane derivatives of the formula ##STR1## wherein R.sub.1 is the residue OR.sub.2 and R.sub.2 is hydrogen, alkyl, cycloalkyl, aryl, or a heterocyclic residue; or is NHR.sub.3 wherein R.sub.3 is an acyl group derived from a hydrocarbon carboxylic or sulfonic acid of up to 15 carbon atoms;A is --CH.sub.2 --CH.sub.2 -- or cis--CH.dbd.CH--Z is carbonyl or ##STR2## wherein the OR.sub.4 group can be in the .alpha.- or .beta.-position and R.sub.4 is H or a hydroxy-protective groupX Y is ##STR3## wherein R.sub.4 is as defined above, --CH.sub.2 -- CH.sub.2 -- or --CH.sub.2 --CH-- wherein R.sub.5 is alkyl or 1-5 carbon atoms, if Z is R.sub.5 carbonyl or ##STR4## X Y represents --CH.dbd.CH-- if Z is carbonyl: R.sub.6, R.sub.7, R.sub.8, R.sub.9 and R.sub.10 each independently is hydrogen or an alkyl group of 1-5 carbon atoms; andR.sub.11 is alkyl of 1-5 carbon atoms;and if R.sub.
    Type: Grant
    Filed: June 29, 1978
    Date of Patent: November 25, 1980
    Assignee: Schering, A.G.
    Inventors: Werner Skuballa, Bernd Raduchel, Helmut Vorbruggen, Walter Elger, Olaf Loge, Ekkehard Schillinger
  • Patent number: 4232173
    Abstract: Synthetic prostaglandin E compounds having carboxylic acid, ester, tetrazol, sulfonamide or imide substitutions at C-1, a methanesulfonamido group replacing the C-15 hydroxy and an aryloxy group at C-16 are disclosed. They exhibit antisecretory biological activity.
    Type: Grant
    Filed: September 17, 1979
    Date of Patent: November 4, 1980
    Assignee: Pfizer Inc.
    Inventors: Thomas K. Schaaf, James F. Eggler